Assessing prognostic value of early tumor shrinkage and depth of response in first-line therapy for patients with advanced unresectable pancreatic cancer

BACKGROUND: The prognostic potential of early tumor shrinkage (ETS) and depth of response (DpR) in pancreatic cancer (PC) is unclear. Here, we recruited 90 patients with recurrent and metastatic PC (RMPC) who had received chemotherapy as first-line therapy to assess the prognostic potential of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaojuan, Xian, Xinghong, Wang, Yongsheng, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281486/
https://www.ncbi.nlm.nih.gov/pubmed/34266410
http://dx.doi.org/10.1186/s12876-021-01870-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281486/
https://www.ncbi.nlm.nih.gov/pubmed/34266410
http://dx.doi.org/10.1186/s12876-021-01870-x

Ejemplares similares